Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

Company Overview - Outset Medical, Inc. is a medical technology company focused on transforming the dialysis experience with innovative technology [3] - The company’s flagship product, the Tablo® Hemodialysis System, is FDA-cleared for use in various settings, from hospitals to home care [3] - Tablo integrates water purification and on-demand dialysate production into a single system, enhancing operational efficiency and patient care [3] Key Presentation Details - Chair & CEO Leslie Trigg will present at the 44th annual J.P. Morgan Healthcare conference on January 14, 2026, at 4:30 p.m. Pacific time [1] - A live and archived webcast of the presentation will be available on the Outset Medical website [2] Market Impact - The Tablo system is currently trusted by over 1,000 healthcare facilities in the U.S. and has facilitated millions of treatments by thousands of nurses [3] - Outset Medical aims to empower healthcare providers to establish in-house dialysis programs, leading to improved operational, clinical, and financial outcomes [3]